Cargando…
Where and Why Modeling Amyotrophic Lateral Sclerosis
Over the years, researchers have leveraged a host of different in vivo models in order to dissect amyotrophic lateral sclerosis (ALS), a neurodegenerative/neuroinflammatory disease that is heterogeneous in its clinical presentation and is multigenic, multifactorial and non-cell autonomous. These mod...
Autores principales: | Liguori, Francesco, Amadio, Susanna, Volonté, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070525/ https://www.ncbi.nlm.nih.gov/pubmed/33921446 http://dx.doi.org/10.3390/ijms22083977 |
Ejemplares similares
-
Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
por: Volonté, Cinzia, et al.
Publicado: (2020) -
Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022) -
Histaminergic transmission slows progression of amyotrophic lateral sclerosis
por: Apolloni, Savina, et al.
Publicado: (2019) -
Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis
por: Apolloni, Savina, et al.
Publicado: (2014) -
Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis
por: Apolloni, Savina, et al.
Publicado: (2017)